Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: A randomised crossover study
- 57 Downloads
Twelve patients with essential hypertension on no other drug treatment were entered into a randomised crossover study of 5, 10 and 20 mg capsules of nifedipine given 3 times a day and 20 mg tablets given twice a day. Each dose was given for 2 weeks in a random order. All forms of nifedipine were effective in lowering blood pressure.
However, 5 mg capsules were less effective than the 10 and 20 mg capsules or 20 mg tablets. There was little to choose between the latter. All doses of nifedipine were more effective 1 and 3 h after the dose compared to subsequent times afterwards. Indeed, as time elapsed after the last dose up to 12 h, there was a gradual increase in blood pressure. However, even at 12 h the 10, 20 mg capsules and 20 mg tablets were still causing an approximate 10% reduction in blood pressure.
Nifedipine tablets are as effective as capsules though they might be longer acting, particurarly around 6 h after the last dose.
Key wordsnifedipine hypertension capsules tablets comparative dose response
Unable to display preview. Download preview PDF.
- Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K, Takikawa K (1978) Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 96: 218–226Google Scholar
- Bailey S, Dobbs RJ, Robinson BF (1982) Nifedipine in the treatment of hypertension: Report of a double blind controlled trial. Br J Clin Pharmacol 14: 509–512Google Scholar
- Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM, Corvol P (1983) Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur J Clin Pharmacol 24: 145–150Google Scholar
- Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA (1985) Sodium restriction lowers high blood pressure through a decreased response of the renin system. Direct evidence using saralasin. J Hypertens 3: 243–247Google Scholar
- Guazzi M, Olivari MT, Polese A, Fiorentini C, Magrini F, Moruzzi P (1977) Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22: 528–532Google Scholar
- Hallin L, Andren L, Hansson L (1983) Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol 5: 1083–1085Google Scholar
- Hornung RS, Gould BA, Jones RI, Sonecha TN, Raftery EB (1983) Nifedipine tablets for systemic hypertension: A study using continuous ambulatory intra-arterial recording. Am J Cardiol 51: 1323–1327Google Scholar
- Jakobsen P, Lederballe Pedersen O, Mikkelsen E (1979) Determination of nifedipine and one of its metabolites using electroncapture detection. J Chromatogr 162: 81–87Google Scholar
- Landmark K (1985) Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets. J Cardiovasc Pharmacol 7: 12–17Google Scholar
- Lederballe Pedersen O, Mikkelsen E (1978) Acute and chronic effects of nifedipine in arterial hypertension. Eur J Clin Pharmacol 14: 375–381Google Scholar
- MacGregor GA, Markandu ND, Rotellar C, Smith SJ, Sagnella GA (1983) The acute response to nifedipine is related to pretreatment blood pressure. Postgrad Med J 59 [Suppl 2]: 91–94Google Scholar
- Marone C, Luisoli S, Bomio F, Beretta Piccoli C, Bianchetti MG, Weidmann P (1984) Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic. J Hypertens 2 [Suppl 3]: 449–452Google Scholar
- Midtbo K, Hals O, van der Meer J (1982) Verapamil compared with nifedipine in the treatment of essential hypertension. J Cardiovasc Pharmacol 4 [Suppl 3]: 363–368Google Scholar
- Ochs HR, Ramsch KD, Verburg-Ochs B, Greenblatt DJ, Gerloff J (1984) Nifedipine: Kinetics and dynamics after single oral doses. Klin Wochenschr 62: 427–429Google Scholar
- Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi MD (1979) Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59: 1056–1062Google Scholar
- Raemsch KD, Sommer J (1983) Pharmacokinetics and metabolism of nifedipine. Hypertension 5 [Suppl 2]: 18–24Google Scholar
- Taburet AM, Singlas E, Colin JN, Banzet O, Thibonnier M, Corvol P (1983) Pharmacokinetic studies of nifedipine tablet — correlation with antihypertensive effects. Hypertension 5 [Suppl 2]: 29–33Google Scholar
- Thibonnier M, Bonnet F, Corvol P (1980) Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension. Eur J Clin Pharmacol 17: 161–164Google Scholar
- Tucker FA, Minty PSB, MacGregor GA (1985) Study of nifedipine photodecomposition in plasma and whole blood using capillary gas liquid chromatography. J Chromatogr 342: 193–198Google Scholar
- Zar JH (1984) Biostatistical analysis (2nd edn). Prentice-Hall, Englewood Cliffs, NJ 07632Google Scholar